{
    "2020-07-02": [
        [
            {
                "time": "2020-07-02",
                "original_text": "北京“火眼”总检测量已达100万人份，7月2日起提供十万人份免费核酸检测",
                "features": {
                    "keywords": [
                        "华大基因",
                        "火眼实验室",
                        "核酸检测",
                        "免费"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-02",
                "original_text": "华大基因拟定增募资20.1亿用于扩大基因检测项目",
                "features": {
                    "keywords": [
                        "华大基因",
                        "定增募资",
                        "基因检测"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-02",
                "original_text": "医药中期策略：迎接后疫情时代，医药优先看好“5+X”",
                "features": {
                    "keywords": [
                        "医药",
                        "后疫情时代",
                        "5+X"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-02",
                "original_text": "电鳗快报|华大基因定增募资20亿元，“边要钱边研发”业绩增长能否恢复？",
                "features": {
                    "keywords": [
                        "华大基因",
                        "定增募资",
                        "研发",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2020-07-02",
                "original_text": "华大基因拟募资20亿元加码主业",
                "features": {
                    "keywords": [
                        "华大基因",
                        "募资",
                        "主业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}